Deferasirox 125 mg / 1 Tablet 30 Tablet, For Suspension
Reference details for licensed healthcare facility review and verification.
| NDC 11 | 62756-0568-83 |
|---|---|
| Product NDC | 62756-0568 |
| Generic Drug Name | deferasirox |
| Brand Name | deferasirox |
| Manufacturer | Sun Pharmaceutical Industries, Inc. |
| Strength | 125 mg / 1 |
| Dosage Form | Tablet |
| Drug Type | Oral |
| Package Quantity | 30 Tablet, For Suspension |
| Package Description | 30 TABLET, FOR SUSPENSION in 1 BOTTLE (62756-568-83) |
| Active Ingredients | Deferasirox |
| Marketing Category | ANDA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
deferasirox 125 mg / 1 Tablet is tracked under NDC 62756-0568-83 and rolls up into product family 62756-0568. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.
- Package configuration: 30 Tablet, For Suspension.
- Manufacturer: Sun Pharmaceutical Industries, Inc..
- Dosage form: Tablet.
- Family size: 2 indexed presentations.
Click a tag to refine the catalog view around this product reference.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Alternate presentations in this family
These nearby package-level pages can help healthcare teams compare related packaging or presentation differences inside the same product-NDC family.
Potential alternatives with matching presentation
Open the comparison hub or review package-level listings from 10 product-NDC families with matching normalized presentation details. Review each product detail page before treating any item as a true alternative.
Deferasirox 125 mg / 1 Tablet 30 Tablet, For Suspension, NDC 62756-0568-83, is a Sun Pharmaceutical Industries, Inc. 125 mg / 1 tablet presentation packaged as 30 Tablet, For Suspension.
NDC search formats
- Canonical NDC 11: 62756-0568-83
- Digits-only NDC 11: 62756056883
- Possible 10-digit display format: 62756-568-83 (6275656883)
Helpful product links
- Search by brand name: deferasirox
- NDC 11: 62756-0568-83
- Product family NDC: 62756-0568
- Other package sizes in this family: 60 Tablet, For Suspension
- Compare related presentations: Deferasirox 125 mg / 1 Tablet 60 Tablet, For Suspension
- VA classification code: AD300
- VA classification code description: HEAVY METAL ANTAGONISTS
- CMOP ID: D1230
- VUID: 4038963